$1.61 4.6%
ATAI Stock Price vs. AI Score (Last 150 days)
Data gathered: July 16

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About ATAI Life Sciences

atai Life Sciences is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, with offices in New York, San Diego and Berlin.

ATAI Life Sciences
Price $1.61
Target Price Sign up
Volume 862,440
Market Cap $258M
Year Range $1.04 - $2.6
Dividend Yield 0%
Revenue per Employee $3,184
Industry Biotechnology

In the news

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '24013M-13M-27M-24M-0.170
Q4 '2318,00020M-20M-18M-33M-0.120
Q3 '2387,00014M-14M44M-27M-0.280
Q2 '23170,00017M-16M-33M-32M-0.210
Q1 '2337,00014M-14M-33M-33M-0.210

Insider Transactions View All

Brand Florian filed to sell 328,697 shares at $1.9.
May 20 '24
Kirpekar Sahil filed to sell 64,199 shares at $1.9.
April 4 '24
Rao Srinivas filed to sell 113,360 shares at $1.9.
April 4 '24
Johnson Anne Nagengast filed to sell 73,590 shares at $1.9.
April 4 '24
Brand Florian filed to buy 130,000 shares at $1.2.
November 20 '23

What is the Market Cap of ATAI Life Sciences?

The Market Cap of ATAI Life Sciences is $258M.

How Many People Work at ATAI Life Sciences?

As of our latest update, ATAI Life Sciences employed approximately 87 people worldwide. However, it's important to note that ATAI Life Sciences' workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is ATAI Life Sciences' revenue per employee?

$3,184. To calculate ATAI Life Sciences' revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current stock price of ATAI Life Sciences?

Currently, the price of one share of ATAI Life Sciences stock is $1.61.

How can I analyze the ATAI stock price chart for investment decisions?

The ATAI stock price chart above provides a comprehensive visual representation of ATAI Life Sciences' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling ATAI Life Sciences shares. Our platform offers an up-to-date ATAI stock price chart, along with technical data analysis and alternative data insights.

Does ATAI offer dividends to its shareholders?

As of our latest update, ATAI Life Sciences (ATAI) does not offer dividends to its shareholders. Investors interested in ATAI Life Sciences should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of ATAI Life Sciences?

Some of the similar stocks of ATAI Life Sciences are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.